Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1...

Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib

Philippe Schafhausen, Judith Dierlamm, Carsten Bokemeyer, Tim H. Bruemmendorf, Ulrike Bacher, Axel R. Zander, Susanne Schnittger, Andreas Hochhaus
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
189
Year:
2009
Language:
english
Pages:
5
DOI:
10.1016/j.cancergencyto.2008.09.016
File:
PDF, 217 KB
english, 2009
Conversion to is in progress
Conversion to is failed